Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.05
+0.17 (2.47%)
Dec 8, 2025, 10:01 AM EST - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $183.33 million as of December 8, 2025. Its market cap has decreased by -58.90% in one year.
Market Cap
183.33M
Enterprise Value
48.12M
1-Year Change
-58.90%
Ranking
Category
Stock Price
$7.05
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $183.33M, an increase of 10.39%. That is a compound annual growth rate of 4.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 178.90M | -61.17% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |